Trident Texofab Ltd reported no deviation in the utilization of funds from its preferential issue of warrants amounting to Rs. 40,86,00,010 for the quarter ended December 31, 2024, confirmed by the Audit Committee.
AI Assistant
Trident Texofab Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.